{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T04:07:08Z","timestamp":1683086828413},"reference-count":20,"publisher":"SLACK, Inc.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gerontol Nurs"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:p>Implications for the Care of Older Adults The information gained through clinical drug trials is valuable, and geriatric nurses must continue to update their knowledge in this area.<\/jats:p>","DOI":"10.3928\/0098-9134-20040101-04","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T19:22:10Z","timestamp":1401304930000},"page":"4-9","source":"Crossref","is-referenced-by-count":0,"title":["What's New About Old Drugs"],"prefix":"10.3928","volume":"30","author":[{"given":"Sunny A","family":"Linnebur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","unstructured":"Chobanian A.V. Bakris G.L. Black H.R. Cushman W.C. Green L.A. Izzo J.L. Jr. Jones D.W. Materson BJ. Oparil S. Wright J.T. Jr. Rocella E.J. & The National High Blood Pressure Education Program Coordinating Commu\u00c3\u00a9e. (2003). The seventh repon of the Joint National Commu\u00c3\u00a9e on Prevention Detection Evaluation and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289(19) 2560-2571."},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. (2001). Executive summary of the third report of the national cholesterol education program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285(19) 2486-2497.","DOI":"10.1001\/jama.285.19.2486"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. (2002a). MRC\/BHF heart protection study of antioxidant vitamin supplementation in 20 536 high-risk individuals: A randomized placebo-controlled trial. Lancet 360(9326) 23-33.","DOI":"10.1016\/S0140-6736(02)09328-5"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"Heart Protection Study Collaborative Group. (2002b). MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: A randomized placebo-controlled trial. Lancet 360(9326) 7-22.","DOI":"10.1016\/S0140-6736(02)09327-3"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"Hyers T.M. Agnelli G. Hull R.D. Morris T.A. Samama M. Tapson V. & Weg J.G. (2001). Antithrombotic therapy for venous thromboembolic disease. Chest 119(Suppl. 1) 176S-193S.","DOI":"10.1378\/chest.119.1_suppl.176S"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"Ott S.M. LaCroix A.Z. Ichikawa L.E. Scholes D. & Barlow W.E. (2003). Effect of low-dose thiazide diuretics on plasma Iipids: Results from a double-blind randomized clinical trial in older men and women. Journal of the American Geriatrics Society 51(3) 340-347.","DOI":"10.1046\/j.1532-5415.2003.51107.x"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"Pavelka K- Gatterova J. Olejarova M. Machacek S. Giacovelli G. & Rovati L.C. (2002). Glucosamine sulfate use and delay of progression of knee osteoarthritis: A 3-year randomized placebo-controlled double-blind study. Archives of Internal Medicine 162(18) 2113-2123.","DOI":"10.1001\/archinte.162.18.2113"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"Raja S.N. Haythornthwaite J.A Pappagallo M. Clark M.R. Travison T.G. Sabeen S. Royall R.M. & Max M.B. (2002). Opioids versus antidepressants in postherpetic neuralgia: A randomized placebo-controlled trial. Neurology 59(7) 1015-1021.","DOI":"10.1212\/WNL.59.7.1015"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"Rathore S.S. Curt\u00c3\u00ads J.P. Wang Y. Bristow M.R. & Krumholz H.M. (2003). Association of serum digoxin concentration and outcomes in patients with heart failure. JA MA 289(7) 871-878.","DOI":"10.1001\/jama.289.7.871"},{"key":"e_1_3_1_11_1","doi-asserted-by":"crossref","unstructured":"Rathore S.S. Wang Y. & Krumholz H.M. (2002). Sex-based differences in the effect of digoxin for the treatment of heart failure. New England Journal of Medicine 347(18) 1403-1411.","DOI":"10.1056\/NEJMoa021266"},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"Reginster J.Y. Deroisy R. Rovati L.C. Lee R.L. Lejeune E. Bruy\u00c3\u00a8re O- Giacovelli G. Henrotin Y. Dacre J.E. K Gossett C. (2001). Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomized placebo-controlled clinical trial. Lancet 357(9252) 251-256.","DOI":"10.1016\/S0140-6736(00)03610-2"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"Ridker P.M. Goldhaber S.Z. Danielson E- Rosenberg Y Eby C.S. Deitcher S.R. Cushman M. Moll S. Kessler C.M. Elliott C.G. Paulson R. Wong T. Bauer K.A. Schwanz B.A. MUetich J.P. Bounameaux H. & Glynn RJ. for the PREVENT Investigators. (2003). Longterm low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism [comment]. New England Journal of Medicine 348(\\5) 1425-1434.","DOI":"10.1056\/NEJMoa035029"},{"key":"e_1_3_1_14_1","doi-asserted-by":"crossref","unstructured":"Shepherd J. Blauw G-J. Murphy M.B. Bollen E.L. Buckley B.M. Gobbe S.M. Ford I- Gaw A. Hyland M. Jukema J.W. Kamper A.M. Macfarlane P.W. Meinders A.E. Nome J. Packard C.J. Perry IJ. Stott D.J. Sweeny B.J. Twomey C. Westendorp R.G.J. on behalf of the PROSPER Study Group. (2002). PravaStatin in elderly individuals at risk of vascular disease (PROSPER): A randomized controlled trial. Lancet 360(9346) 1623-1630.","DOI":"10.1016\/S0140-6736(02)11600-X"},{"key":"e_1_3_1_15_1","unstructured":"Shults C.W. Oakes D. Kieburtz K. Beai M.F. Haas R. Plumb S. Juncos J.L. Nutt J. Shoulson I. Carter J. Kompoliti K. Perlmutter J.S. Reich S. Stern M. Watts R.L. Kurlan R. Molho E. Harrison M. Lew M. & the Parkinson Study Group. (2002). Effects of coenzyme Q10 in early Parkinson disease: Evidence of slowing of the functional decline. Archives of Neurology 59(10) 1541-1550."},{"key":"e_1_3_1_16_1","doi-asserted-by":"crossref","unstructured":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. (2000). Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: The antihypertensive and l\u00c3\u00adpid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA 2SJ(IS) 1967-1975.","DOI":"10.1001\/jama.283.15.1967"},{"key":"e_1_3_1_17_1","doi-asserted-by":"crossref","unstructured":"The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. (2002). Major outcomes in highrisk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) JAMA 288(23) 2981-2997.","DOI":"10.1001\/jama.288.23.2981"},{"key":"e_1_3_1_18_1","doi-asserted-by":"crossref","unstructured":"The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. (2002). A comparison of rate control and rhythm control in patients with atrial fibrillation. New England Journal of Medicine 347(23) 1825-1833.","DOI":"10.1056\/NEJMoa021328"},{"key":"e_1_3_1_19_1","doi-asserted-by":"crossref","unstructured":"The Digitalis Investigation Group. (1997). The effect of digoxin on mortality and morbidity in patients with heart failure. New England Journal of Medicine 336(9) 525-533.","DOI":"10.1056\/NEJM199702203360801"},{"key":"e_1_3_1_20_1","doi-asserted-by":"crossref","unstructured":"Wing L.M. Reid C.M. Ryan P. Beilin L.J. Brown M.A. Jennmgs G.L. Johnston CL McNeil J.J. Macdonald GJ. Marley J.E. Morgan TO. & West MJ. for the Second Australian National Blood Pressure Study Group. (2003). A comparison of outcomes with angiotensin-converting - Enzyme inhibitors and diuretics for hypertension in the elderly. New England Journal of Medicine 348(7) 583-592.","DOI":"10.1056\/NEJMoa021716"},{"key":"e_1_3_1_21_1","doi-asserted-by":"crossref","unstructured":"Writing Group for the Women's Health Initiative. (2002). Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288(3) 321-333.","DOI":"10.1001\/jama.288.3.321"}],"container-title":["Journal of Gerontological Nursing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/doiresolver?doi=10.3928\/0098-9134-20040101-04","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T22:52:00Z","timestamp":1683067920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0098-9134-20040101-04"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.3928\/0098-9134-20040101-04"],"URL":"https:\/\/doi.org\/10.3928\/0098-9134-20040101-04","relation":{},"ISSN":["0098-9134","1938-243X"],"issn-type":[{"value":"0098-9134","type":"print"},{"value":"1938-243X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}